The development of a personalized approach in the treatment of chronic rhinosinusitis with nasal polyps

Moiseeva Yu.P.; Piskunov G.Z.

doi:https://doi.org/10.17116/otorino20228703140

Close metadata

Recommended articles:

Antifungal immunity in patients with chronic rhinosinusitis with nasal polyps. Russian Bulletin of Otorhinolaryngology. 2024;(6):40-45

A case of prolonged remission after discontinuation of biological therapy in a patient with severe uncontrolled chronic rhinosinusitis with nasal polyps. Russian Bulletin of Otorhinolaryngology. 2024;(6):99-106

Monoclonal antibodies in the treatment of recurrent polyposis rhinosinusitis. Literature review. Russian Bulletin of Otorhinolaryngology. 2025;(4):96-104

Gut microbiota: role in human health and potential for personalized medicine. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):81-88

Personalized approach to treatment choice using a digital profile of patient with cardiovascular diseases: the features of clinical decision-making support service. Russian Cardiology Bulletin. 2024;(4-2):105-112

Regenerative capabilities of platelet-rich plasma in different age groups. Pirogov Russian Journal of Surgery. 2025;(5):36-43

Synergistic efficiency of preformed physical factors and dupilumab in the treatment of polypous rhinosinusitis. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2025;(2):16-23

Relationship between oxidative stress patterns and proinflammatory cytokines in patients with polypous rhinosinusitis under the course of therapeutic physical factors. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2025;(2):42-49

The role of TRP channels in migraine. Russian Journal of Pain. 2025;(3):93-103

Mechanisms of additivity of physiotherapeutic factors in complex therapy of polypous rhinosinusitis complicated by comorbidities. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2025;(3):5-11

Abstract:

Due to the high recurrence rate and the variety of complex pathogenesis mechanisms, chronic rhinosinusitis with nasal polyps is difficult to treat. In addition, the disease reduces the quality of life of patients and carries a large financial burden on the healthcare system, therefore, a personalized approach to the treatment of this pathology is becoming popular today. In order to determine which drug route would be most rational for a particular patient, key concepts such as phenotyping, endotyping and genotyping of chronic rhinosinusitis with nasal polyps were introduced. This approach has expanded the understanding of the etiological aspects of the disease and the pathogenetic mechanisms of the formation of nasal polyps. In this regard, immunotherapy of chronic rhinosinusitis with nasal polyps began to develop, consisting in the use of monoclonal antibodies to the substrates of the immune system, which are key figures in the development of certain types of inflammatory reactions of the mucous membrane of the nasal cavity and paranasal sinuses. The use of biological agents represents the first steps in targeted therapy, which is a transition to personalized treatment of patients with chronic rhinosinusitis with nasal polyps. Further studies in the field of immunological mechanisms of the formation of various phenotypes of chronic rhinosinusitis with nasal polyps from the standpoint of proteinomics, transcriptomics and epigenetics give hope for the development of a new drug-based treatment for this disease, which can significantly reduce the need for surgical treatment of patients with this pathology.

Keywords:

chronic rhinosinusitis with nasal polyps

genotyping

phenotyping

endotyping

precision medicine

Authors:

Moiseeva Yu.P.

Russian Medical Academy of Continuing Professional Education

SPIN RSCI: 8467-6029
Scopus AuthorID: 57216932576
ORCID: 0000-0001-6063-3043

Piskunov G.Z.

Russian Medical Academy of Continuing Professional Education

Received:

14.04.2020

Accepted:

14.12.2021

Close metadata

References:

Avdeeva SN. The prevalence of diseases of ENT organs among the urban population at the present stage. Rossijskaya otorinolaringologiya. 2006;3:33-37. (In Russ.).
Skazatova NYu, Piskunov GZ. The prevalence of diseases of the ear, throat and nose in the urban population. Kremlevskaya meditsina. 2016;1:5-10. (In Russ.).
Piskunov GZ. Klinicheskaya rinologiya. 3-e izd. M.: Meditsinskoe informatsionnoe agentstvo. 2017. (In Russ.).
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang de Y, Wormald PJ. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinology. 2012;50(1):1-12. https://doi.org/10.4193/Rhino50E2.
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, Toppila-Salmi S, Bernal-Sprekelsen M, Mullol J, Alobid I, Terezinha Anselmo-Lima W, Bachert C, Baroody F, von Buchwald C, Cervin A, Cohen N, Constantinidis J, De Gabory L, Desrosiers M, Diamant Z, Douglas RG, Gevaert PH, Hafner A, Harvey RJ, Joos GF, Kalogjera L, Knill A, Kocks JH, Landis BN, Limpens J, Lebeer S, Lourenco O, Meco C, Matricardi PM, O’Mahony L, Philpott CM, Ryan D, Schlosser R, Senior B, Smith TL, Teeling T, Tomazic PV, Wang DY, Wang D, Zhang L, Agius AM, Ahlstrom-Emanuelsson C, Alabri R, Albu S, Alhabash S, Aleksic A, Aloulah M, Al-Qudah M, Alsaleh S, Baban MA, Baudoin T, Balvers T, Battaglia P, Bedoya JD, Beule A, Bofares KM, Braverman I, Brozek-Madry E, Richard B, Callejas C, Carrie S, Caulley L, Chussi D, de Corso E, Coste A, El Hadi U, Elfarouk A, Eloy PH, Farrokhi S, Felisati G, Ferrari MD, Fishchuk R, Grayson W, Goncalves PM, Grdinic B, Grgic V, Hamizan AW, Heinichen JV, Husain S, Ping TI, Ivaska J, Jakimovska F, Jovancevic L, Kakande E, Kamel R, Karpischenko S, Kariyawasam HH, Kawauchi H, Kjeldsen A, Klimek L, Krzeski A, Kopacheva Barsova G, Kim SW, Lal D, Letort JJ, Lopatin A, Mahdjoubi A, Mesbahi A, Netkovski J, Nyenbue Tshipukane D, Obando-Valverde A, Okano M, Onerci M, Ong YK, Orlandi R, Otori N, Ouennoughy K, Ozkan M, Peric A, Plzak J, Prokopakis E, Prepageran N, Psaltis A, Pugin B, Raftopulos M, Rombaux P, Riechelmann H, Sahtout S, Sarafoleanu CC, Searyoh K, Rhee CS, Shi J, Shkoukani M, Shukuryan AK, Sicak M, Smyth D, Sindvongs K, Soklic Kosak T, Stjarne P, Sutikno B, Steinsvag S, Tantilipikorn P, Thanaviratananich S, Tran T, Urbancic J, Valiulius A, Vasquez de Aparicio C, Vicheva D, Virkkula PM, Vicente G, Voegels R, Wagenmann MM, Wardani RS, Welge-Lussen A, Witterick I, Wright E, Zabolotniy D, Zsolt B, Zwetsloot CP. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. https://doi.org/10.4193/Rhin20.600
Rudmik L. Economics of Chronic Rhinosinusitis. Current Allergy and Asthma Reports. 2017;17(4):20. https://doi.org/10.1007/s11882-017-0690-5
Kim DW, Cho SH. Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine. Allergy, Asthma and Immunology Research. 2017;9(4):299-306. https://doi.org/10.4168/aair.2017.9.4.299
Piskunov GZ. Physiological and pathophysiological substantiation of functional rhinosinusosurgery. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2018;24(1):23-28. (In Russ.).
Cho SH, Bachert C, Lockey RF. Chronic rhinosinusitis phenotypes: an approach to better medical care for chronic rhinosinusitis. The Journal of Allergy and Clinical Immunology. In Practice. 2016;4(4):639-642. https://doi.org/10.1016/j.jaip.2016.05.007
Ryazantsev SV, Lopatin AS, Piskunov GZ, Karneeva OV. Klinicheskie rekomendatsii. Polipoznyj rinosinusit. M.—SPb; 2014. (In Russ.).
Mygind N. Nasal polyps. In: Mygind N, ed. Nasal Allergy. Oxford: Blackwell Scientific Publications; 1978.
Lou H, Zhang N, Bachert C, Zhang L. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. International Forum of Allergy and Rhinology. 2018;8(11):1218-1225. https://doi.org/10.1002/alr.22214
Mahdavinia M, Carter RG, Ocampo CJ, Stevens W, Kato A, Tan BK, Kern RC, Conley DB, Chandra R, Hulse KE, Suh LA, Norton JE, Peters AT, Grammer LC, Schwartz LB, Schleimer RP. Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity. The Journal of Allergy and Clinical Immunology. 2014;133(6):1759-1763. https://doi.org/0.1016/j.jaci.2013.12.1092
Dennis SK, Lam K, Luong A. A Review of Classification Schemes for Chronic Rhinosinusitis with Nasal Polyposis Endotypes. Laryngoscope Investigative Otolaryngology. 2016;1(5):130-134. https://doi.org/10.1002/lio2.32
Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, Förster-Ruhrmann U, Kowalski ML, Olszewska-Ziąber A, Holtappels G, De Ruyck N, Wang X, Van Drunen C, Mullol J, Hellings P, Hox V, Toskala E, Scadding G, Lund V, Zhang L, Fokkens W, Bachert. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. The Journal of Allergy and Clinical Immunology. 2016;137(5):1449-1456.e4. https://doi.org/10.1016/j.jaci.2015.12.1324
Dinarte VR, Santos AR, Araújo LF, Reis MG, Tamashiro E, Valera FC, Silva Júnior WAD, Anselmo-Lima WT. Polymorphisms in chronic rhinosinusitis with nasal polyps — a systematic review. Brazilian Journal of Otorhinolaryngology. 2017;83(6):705-711. https://doi.org/10.1016/j.bjorl.2017.03.002
Oakley GM, Curtin K, Orb Q, Schaefer C, Orlandi RR, Alt JA. Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment. International Forum of Allergy and Rhinology. 2015;5(4):276-282. https://doi.org/10.1002/alr.21469
Greisner WA, Settipane GA. Hereditary factor for nasal polyps. Allergy and Asthma Proceedings. 1996;17(5):283-286. https://doi.org/10.2500/108854196778662192
Leung ML, Watson DJ, Vaccaro CN, Mafra F, Wenocur A, Wanget T, Hakonarson H, Santani A. Evaluating sequence data quality from the Swift Accel-Amplicon CFTR Panel. Scientific Data. 2020;7(1):8. https://doi.org/10.1038/s41597-019-0339-4
Lima CS, Ortega MM, Marson FA, Zulli R, Ribeiro AF, Bertuzzo CS. Cystic fibrosis transmembrane conductance regulator gene mutations and glutathione S-transferase null genotypes in cystic fibrosis patients in Brazil. Jornal Brasileiro de Pneumologia. 2012;38(1):50-56. https://doi.org/10.1590/s1806-37132012000100008
Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, von Mutius E, Farrall M, Lathrop M, Cookson WOCM; GABRIEL Consortium. A Large-Scale, Consortium-Based Genomewide Association Study of Asthma. New England Journal of Medicine. 2010;363(13):1211-1221. https://doi.org/10.1056/nejmoa0906312
Shrine N, Portelli MA, John C, Soler Artigas M, Bennett N, Hall R, Lewis J, Henry AP, Billington CK, Ahmad A, Packer RJ, Shaw D, Pogson ZEK, Fogarty A, McKeever TM, Singapuri A, Heaney LG, Mansur AH, Chaudhuri R, Thomson NC, Holloway JW, Lockett GA, Howarth PH, Djukanovic R, Hankinson J, Niven R, Simpson A, Chung KF, Sterk PJ, Blakey JD, Adcock IM, Hu S, Guo Y, Obeidat M, Sin DD, van den Berge M, Nickle DC, Bossé Y, Tobin MD, Hall IP, Brightling CE, Wain LV, Sayers I. Moderate-to-severe asthma in individuals of European ancestry: A genome-wide association study. The Lancet Respiratory Medicine. 2018;7(1):20-34. https://doi.org/10.1016/S2213-2600(18)30389-8
Park JS, Son JH, Park CS, Chang HS. Clinical Implications of Single Nucleotide Polymorphisms in Diagnosis of Asthma and its Subtypes. Yonsei Medical Journal. 2019;60(1):1-9. https://doi.org/10.3349/ymj.2019.60.1.1
Levchenko AS. Genetic aspects of polypous rhinosinusitis. Genetika. 2018;54(8):904-914. (In Russ.).
Buysschaert ID, Grulois V, Eloy P, Jorissen M, Rombaux P, Bertrand B, Collet S, Bobic S, Vlaminck S, Hellings PW, Lambrechts D. Genetic evidence for a role of IL33 in nasal polyposis. Allergy. 2010;65(5):616-622. https://doi.org/10.1111/j.1398-9995.2009.02227.x
Cai C, Zhou MX, Li YP, Chen CS. Association of leukotriene gene polymorphisms with response to antileukotriene treatment in patients with asthma. Zhonghua Jie He He Hu Xi Za Zhi. 2011;34(5):362-366.
Berdnikova NG, Zhuravleva MV, Pushkina SL, Lazareva NB. The possibilities of personalized pharmacotherapy of bronchial asthma. Klinicheskaya farmakologiya i terapiya. 2014;23(5):27-33. (In Russ.).
Kondo N, Matsui E, Nishimura A, Kaneko H. Pharmacogenetics of asthma in children. Allergy, Asthma and Immunology Research. 2010;2(1):14-19. https://doi.org/10.4168/aair.2010.2.1.14
Shpork P. Chitaya mezhdu strok DNK. Vtoroj kod nashej zhizni, ili Kniga, kotoruyu nuzhno prochitat’ vsem. M.: Lomonosov; 2020. (In Russ.).
Endam LM, Filali-Mouhim A, Boisvert P, Boulet L-P, Bosse Y, Desrosiers M. Genetic variations in taste receptors are associated with chronic rhinosinusitis: A replication study. International Forum of Allergy and Rhinology. 2014;4(3):200-206. https://doi.org/10.1002/alr.21275
Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, Canonica GW, Deneyer L, Desrosiers M, Diamant Z, Han J, Heffler E, Hopkins C, Jankowski R, Joos G, Knill A, Lee J, Lee SE, Mariën G, Pugin B, Senior B, Seys SF, Hellings PW. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74(12):2312-2319. https://doi.org/10.1111/all.13875